Skip to main content
SpringerLink
Log in

Clinical usefulness of positron emission tomography with fluorine-18-fluorodeoxyglucose in the diagnosis of liver tumors

  • Original Articles
  • Published:
Annals of Nuclear Medicine Aims and scope Submit manuscript

Abstract

We studied various liver tumors by positron emission tomography with fluorine-18 fluorodeoxyglucose (FDG-PET) to examine the diagnostic usefulness of this technique. We also examined the relation between findings on FDG-PET and the characteristics of hepatocellular carcinoma.

FDG-PET was performed in 78 patients with liver tumors, including 53 with primary liver cancer [48 hepatocellular carcinomas (HCC) and 5 cholangiocellular carcinomas (CCC)], 20 with metastatic liver cancer, 2 with liver hemangioma, and 3 with focal nodular hyperplasia. For quantitative evaluation, a region of interest (ROI) was placed over the entire tumor region, at the level of the maximum diameter of the tumor. A background ROI was then placed over the non-tumor region of the liver. The average activity within each ROI was subsequently corrected for radioactive decay, and the standardized uptake value (SUV) was calculated by dividing the tissue activity by the injected dose of radioactivity per unit body weight. SUV ratio was expressed as the tumor-to-non-tumor ratio of the SUV.

The median SUV was significantly lower in HCC than in metastatic live cancer or CCC, and the median SUV ratio was significantly lower in HCC than in metastatic liver cancer or CCC. The median SUV was not higher in multiple HCC than in single HCC, but the median SUV ratio was significantly higher in multiple HCC than in single HCC. The median SUV and the median SUV ratio were significantly higher in the presence of portal vein thrombosis than in the absence of such thrombosis. The Cancer of the Liver Italian Program score and the α-fetoprotein value correlated significantly with both the SUV and SUV ratio. These results suggest that FDG-PET is clinically useful not only for the differential diagnosis of liver tumors but also for evaluation of the clinical characteristics of HCC.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Warburg O, Wind F, Negelein E. On the metabolism of Tumors in the body.In: Warburg O, ed. The Metabolism of Tumors. London, Constable, pp. 254–265, 1930.

    Google Scholar 

  2. Sweeney MJ, Ashmore J, Morris HP, Weber G. Comparative biochemistry of hepatomas. IV. Isotope studies of glucose and fructose metabolism in liver tumors of different growth rates.Cancer Res 23: 995–1002, 1963.

    PubMed  CAS  Google Scholar 

  3. Lo C, Cristrofalo VJ, Morris HP, Weinhouse S. Studies on respiration and glycolysis in transplanted hepatic tumors of the rat.Cancer Res 28: 1–10, 1968.

    PubMed  CAS  Google Scholar 

  4. Burk D, Woods M, Hunter J. On the significance of glucolysis for cancer growth, with special reference to Morris rat hepatomas.J Natl Cancer Inst 38: 839–863, 1967.

    PubMed  CAS  Google Scholar 

  5. DiChiro G, DeLaPaz RL, Brooks RA, Sokoloff L, Komblith PL, Smith BH, et al. Glucose utilization of cerebral gliomas measured by [18F]fluorodeoxyglucose and positron emission tomography.Neurology 32: 1323–1329, 1982.

    CAS  Google Scholar 

  6. Okazumi S, Isono K, Enomoto K, Kikuchi T, Ozaki M, Yamamoto H, et al. Evaluation of liver tumors using fluorine-18-fluorodeoxy-glucose PET: Characterization of tumor and assessment of effect of treatment.J Nucl Med 33: 333–339, 1992.

    PubMed  CAS  Google Scholar 

  7. Messa C, Choi Y, Hoh CK, Jacobs EL, Glaspy JA, Rege S, et al. Quantification of glucose utilization in liver metastases: parametric imaging of FDG uptake with PET.J Comput Assist Tomogr 16: 684–689, 1992.

    Article  PubMed  CAS  Google Scholar 

  8. The cancer of the liver Italian program (CLIP) investigator. A new prognostic system for hepatocellular carcinoma: a retrospective study of 435 patients.Hepatology 28: 751–755, 1998.

    Article  Google Scholar 

  9. Pugh RN, Murray-Lyon IM, Dawson JL, Pietroni MC, Williams R. Transection of the oesophagus for bleeding oesophageal varices.Br J Surg 60: 646–649, 1973.

    Article  PubMed  CAS  Google Scholar 

  10. Takayasu K, Kasugai H, Ikeya S, Muramatsu Y, Moriyama N, Makuuchi M, et al. A clinical and radiologic study of primary liver cancer associated with extrahepatic primary cancer.Cancer 69: 45–51, 1992.

    Article  PubMed  CAS  Google Scholar 

  11. De Santis M, Romagnori R, Cristani A, Cioni G, Casolo A, Vici FF, et al. MRI of small hepatocellular carcinoma: comparison with US, CT, DSA, and Lipiodol-CT.J Comput Assist Tomogr 16: 189–197, 1992.

    Article  PubMed  Google Scholar 

  12. Ogunbiyi OA, Flanagan FL, Dehdashti F, Siegel BA, Trask DD, Birnbaum EH, et al. Detection of recurrent and metastatic colorectal cancer: comparison of positron emission tomography and computed tomography.Ann Surg Oncol 4: 613–620, 1997.

    Article  PubMed  CAS  Google Scholar 

  13. Crippa F, Gavazzi C, Bozzetti F, Chiesa C, Pascali C, Bogni A, et al. The influence of blood glucose levels on [18F] fluorodeoxyglucose (FDG) uptake in cancer: a PET study in liver metastases from colorectal carcinomas.Tumori 83: 748–752, 1997.

    PubMed  CAS  Google Scholar 

  14. Yonekura Y, Benua RS, Brill AB, Som P, Yeh SDJ, Kemeny NE, et al. Increased accumulation of 2-deoxy-2-F-18-fluoro-d-glucose in liver metastases from colon carcinoma.J Nucl Med 23: 1133–1137, 1982.

    PubMed  CAS  Google Scholar 

  15. Paulus P, Hustinx R, Daenen F, Jacquet N, Rigo P. Usefulness of 18-FDG positron emission tomography in detection and follow up of digestive cancers.Acta Gastroenterol Belg 60: 278–280, 1997.

    PubMed  CAS  Google Scholar 

  16. Itai Y, Araki T, Furui S, Tasaka A. Differential diagnosis of hepatic masses on computed tomography, with particular reference to hepatocellular carcinoma.J Comput Assist Tomogr 5: 834–842, 1981.

    Article  PubMed  CAS  Google Scholar 

  17. Keiding S, Hansen SB, Rasmussen HH, Gee A, Kruse A, Roelsgaard K, et al. Detection of cholangiocarcinoma in primary sclerosing cholangitis by positron emission tomography.Hepatology 28: 700–706, 1998.

    Article  PubMed  CAS  Google Scholar 

  18. Shiomi S, Sasaki N, Kawashima D, Jomura H, Fukuda T, Kuroki T, et al. Combined hepatocellular carcinoma and cholangiocarcinoma with high F-18 fluorodeoxyglucose positron emission tomographic uptake.Clin Nucl Med 24: 370–371, 1999.

    Article  PubMed  CAS  Google Scholar 

  19. Torizuka T, Tamaki N, Inokuma T, Magata Y, Sasayama S, Yonekura Y, et al.In vivo assessment of glucose metabolism in hepatocellular carcinoma with FDG-PET.J Nucl Med 36: 1811–1817, 1995.

    PubMed  CAS  Google Scholar 

  20. Megyesi C, Samols E, Marks V. Glucose tolerance and diabetes in chronic liver disease.Lancet 2: 1051–1056, 1967.

    Article  PubMed  CAS  Google Scholar 

  21. Langen KJ, Braun U, Rota Kops E, Herzog H, Kuwert T, Nebeling B, et al. The influence of plasma glucose levels on fluorine-18-fluorodeoxyglucose uptake in bronchial carcinomas.J Nucl Med 34: 355–359, 1993.

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Nuclear Medicine, Osaka City University Medical School, 1-4-3 Asahimachi, Abeno-ku, 545-8585, Osaka, Japan

    Joji Kawabe & Hironobu Ochi

  2. Third Department of Internal Medicine, Osaka City University Medical School, 1-4-3 Asahimachi, Abeno-ku, 545-8585, Osaka, Japan

    Yoshinori Iwata, Susumu Shiomi, Nobumitsu Sasaki, Hisato Jomura, Shuhei Nishiguchi & Shuichi Seki

Authors
  1. Yoshinori Iwata
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Susumu Shiomi
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Nobumitsu Sasaki
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Hisato Jomura
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Shuhei Nishiguchi
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Shuichi Seki
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Joji Kawabe
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Hironobu Ochi
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Yoshinori Iwata.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Iwata, Y., Shiomi, S., Sasaki, N. et al. Clinical usefulness of positron emission tomography with fluorine-18-fluorodeoxyglucose in the diagnosis of liver tumors. Ann Nucl Med 14, 121–126 (2000). https://doi.org/10.1007/BF02988591

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02988591

Key words

Search

Navigation